Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon Alfa-2a vs Hydroxyurea in High Risk PV and ET
NCT01259856Phase 3Completed
- Start
- Sep 2011
- Primary completion
- Jun 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 4
01
Overview
A Phase 3 trial of peginterferon alfa-2a in polycythemia vera (PV), essential thrombocythemia (ET). Started Sep 2011; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
polycythemia vera (PV)essential thrombocythemia (ET)
Beyond the preview
Go deeper on NCT01259856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259856.